Skip to main content
Top
Published in: Netherlands Heart Journal 3/2018

Open Access 01-03-2018 | Review Article

Athletes with channelopathy may be eligible to play

Authors: N. M. Panhuyzen-Goedkoop, A. A. M. Wilde

Published in: Netherlands Heart Journal | Issue 3/2018

Login to get access

Abstract

The European and Bethesda recommendations roughly state that any athlete with channelopathy is not eligible to participate in sports on a presumed risk of potentially life-threatening ventricular tachycardia or fibrillation. However, eligibility decision-making on a presumed risk of ventricular tachycardia or fibrillation is debatable. Channelopathies are primary electrical cardiac disorders and are usually transmitted as an autosomal dominant trait. Some of the channelopathies are potentially fatal in relation to exercise and predispose to life-threatening cardiac arrhythmias including ventricular tachycardia or fibrillation. Exercise, swimming, body heating and electrolyte depletion can all act as a trigger of ventricular tachycardia or fibrillation in channelopathy. However, new research mentioned a very low incidence of ventricular tachycardia or fibrillation in athletes with channelopathy challenging the decision of disqualification. Recently, the American recommendations for sports participation in athletes with a cardiovascular disorder have updated their eligibility decision-making.
In this manuscript we describe the signature features of the electrocardiogram changes in channelopathies and we argue that new research data should allow for the introduction of more liberal eligibility decision-making for sports participation in athletes with channelopathy, not only in the United States but also in European countries.
Literature
1.
go back to reference Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/EHRA/APHRS consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932–63.CrossRefPubMed Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/EHRA/APHRS consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932–63.CrossRefPubMed
2.
go back to reference Priori SG, Blömstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;2015:2793–867.CrossRef Priori SG, Blömstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;2015:2793–867.CrossRef
3.
go back to reference Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782–4.CrossRefPubMed Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782–4.CrossRefPubMed
4.
go back to reference Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659–70.CrossRefPubMed Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659–70.CrossRefPubMed
5.
go back to reference Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119:1085–92.CrossRefPubMed Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119:1085–92.CrossRefPubMed
7.
9.
go back to reference Pelliccia A, Fagard R, Bjornstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J. 2005;26:1422–45.CrossRefPubMed Pelliccia A, Fagard R, Bjornstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J. 2005;26:1422–45.CrossRefPubMed
10.
go back to reference Heidbuchel H, Corrado D, Biffi A, et al. Recommendations for participation in recreational physical activity and competitive sports for patients with arrhythmias and potential arrhythmogenic conditions. Part II: ventricular arrhythmia. channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13:676–86.CrossRefPubMed Heidbuchel H, Corrado D, Biffi A, et al. Recommendations for participation in recreational physical activity and competitive sports for patients with arrhythmias and potential arrhythmogenic conditions. Part II: ventricular arrhythmia. channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13:676–86.CrossRefPubMed
11.
go back to reference Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited: a comparison of US and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990–6.CrossRefPubMed Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited: a comparison of US and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990–6.CrossRefPubMed
12.
go back to reference Zipes DP, Ackerman MJ, Estes NAM 3rd, et al. Task Force 7: arrhythmias. J Am Coll Cardiol. 2005;45:1354–63.CrossRefPubMed Zipes DP, Ackerman MJ, Estes NAM 3rd, et al. Task Force 7: arrhythmias. J Am Coll Cardiol. 2005;45:1354–63.CrossRefPubMed
13.
go back to reference Johnson JN, Ackerman MJ. Return to play? Athletes with congenital long QT syndrome. Br J Sports Med. 2013;47:28–33.CrossRefPubMed Johnson JN, Ackerman MJ. Return to play? Athletes with congenital long QT syndrome. Br J Sports Med. 2013;47:28–33.CrossRefPubMed
14.
go back to reference Lampert R, Olshansky B, Heidbuchel H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators. Results of a prospective, multinational registry. Circulation. 2013;127:2021–30.CrossRefPubMed Lampert R, Olshansky B, Heidbuchel H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators. Results of a prospective, multinational registry. Circulation. 2013;127:2021–30.CrossRefPubMed
15.
go back to reference Ostby SA, Bos JM, Owen HJ, et al. Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia. A single center’s early experience. J Am Coll Cardiol. 2016;2:253–62. Ostby SA, Bos JM, Owen HJ, et al. Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia. A single center’s early experience. J Am Coll Cardiol. 2016;2:253–62.
16.
go back to reference Masrur S, Memon S, Thompson PD. Brugada syndrome, exercise, and exercise testing. Clin Cardiol. 2015;38:323–6.CrossRefPubMed Masrur S, Memon S, Thompson PD. Brugada syndrome, exercise, and exercise testing. Clin Cardiol. 2015;38:323–6.CrossRefPubMed
17.
go back to reference Ackerman MJ, Zipes DP, Kovacs RJ, et al. AHA/ACC scientific statement eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies. A scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e326–e9.CrossRefPubMed Ackerman MJ, Zipes DP, Kovacs RJ, et al. AHA/ACC scientific statement eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies. A scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e326–e9.CrossRefPubMed
18.
go back to reference Maron BJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e256–e61.CrossRefPubMed Maron BJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e256–e61.CrossRefPubMed
19.
go back to reference Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–e80.CrossRefPubMed Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–e80.CrossRefPubMed
20.
go back to reference Mitchell JH, Haskell W, Snell P, et al. Task force 8: classification of sports. J Am Coll Cardiol. 2005;45:1364–7.CrossRefPubMed Mitchell JH, Haskell W, Snell P, et al. Task force 8: classification of sports. J Am Coll Cardiol. 2005;45:1364–7.CrossRefPubMed
21.
go back to reference Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardioavascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial disease of the European Society of Cardiology. Eur Heart J. 2005;26:516–20.CrossRefPubMed Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardioavascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial disease of the European Society of Cardiology. Eur Heart J. 2005;26:516–20.CrossRefPubMed
22.
go back to reference Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation, Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31:243–59.CrossRef Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation, Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31:243–59.CrossRef
23.
go back to reference Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’. Br J Sports Med. 2013;47:122–4.CrossRefPubMed Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’. Br J Sports Med. 2013;47:122–4.CrossRefPubMed
24.
go back to reference Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. J Am Coll Cardiol. 2017;69:1057–75.CrossRefPubMed Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. J Am Coll Cardiol. 2017;69:1057–75.CrossRefPubMed
26.
go back to reference Drezner JA, Sharma S, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. Br J Sports Med. 2017;51:704–31.CrossRefPubMed Drezner JA, Sharma S, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. Br J Sports Med. 2017;51:704–31.CrossRefPubMed
27.
go back to reference Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med. 2013;47:153–67.CrossRefPubMed Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med. 2013;47:153–67.CrossRefPubMed
29.
go back to reference Golob M, Redpath C, Roberts J. The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol. 2010;57:802–12.CrossRef Golob M, Redpath C, Roberts J. The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol. 2010;57:802–12.CrossRef
30.
go back to reference Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol. 2004;43:1494–9.CrossRefPubMed Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol. 2004;43:1494–9.CrossRefPubMed
31.
go back to reference Duhtia H, Malhotra A, Parpia S, et al. The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes. Br J Sports Med. 2016;50:124–9.CrossRef Duhtia H, Malhotra A, Parpia S, et al. The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes. Br J Sports Med. 2016;50:124–9.CrossRef
32.
go back to reference Antonen O, Junttila MJ, Rissanen H, et al. Prevalence and prognostic significance of short QT interval in a middle aged Finnish population. Circulation. 2007;116:14–20.CrossRef Antonen O, Junttila MJ, Rissanen H, et al. Prevalence and prognostic significance of short QT interval in a middle aged Finnish population. Circulation. 2007;116:14–20.CrossRef
33.
go back to reference Funada A, Hayashi K, Ino H, et al. Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol. 2008;31:270–4.CrossRefPubMed Funada A, Hayashi K, Ino H, et al. Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol. 2008;31:270–4.CrossRefPubMed
34.
go back to reference Kobza R, Roos M, Niggli B, et al. Prevalence of long and short QT in a young population in 41,767 predominantly male Swiss conscripts. Heart Rhythm. 2009;6:652–7.CrossRefPubMed Kobza R, Roos M, Niggli B, et al. Prevalence of long and short QT in a young population in 41,767 predominantly male Swiss conscripts. Heart Rhythm. 2009;6:652–7.CrossRefPubMed
35.
go back to reference Iribarren C, Round AD, Peng JA, et al. Short QT in a cohort of 1.7 million persons: prevalence, correlated, and prognosis. Ann Noninvasive Electrocardiol. 2014;19:490–500.CrossRefPubMed Iribarren C, Round AD, Peng JA, et al. Short QT in a cohort of 1.7 million persons: prevalence, correlated, and prognosis. Ann Noninvasive Electrocardiol. 2014;19:490–500.CrossRefPubMed
36.
go back to reference Panhuyzen-Goedkoop NM, Wilde AAM. Channelopathy in athletes. In: Pelliccia A, Heidbuchel H, Sharma S, editors. The ESC textbook of sports cardiology. Oxford: Oxford University Press; 2018. Panhuyzen-Goedkoop NM, Wilde AAM. Channelopathy in athletes. In: Pelliccia A, Heidbuchel H, Sharma S, editors. The ESC textbook of sports cardiology. Oxford: Oxford University Press; 2018.
37.
go back to reference Gottschalk B, Anselm DD, Baranchuk A. Brugada phenocopies are the leading differential diagnosis of Brugada syndrome. Clin Med. 2015;15:380–311.CrossRef Gottschalk B, Anselm DD, Baranchuk A. Brugada phenocopies are the leading differential diagnosis of Brugada syndrome. Clin Med. 2015;15:380–311.CrossRef
38.
go back to reference Antzelevitch C, Yan GX, Ackerman MJ, et al. J‑wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;13:e295–e324.CrossRefPubMedPubMedCentral Antzelevitch C, Yan GX, Ackerman MJ, et al. J‑wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;13:e295–e324.CrossRefPubMedPubMedCentral
41.
go back to reference Blanco M, Bria S, Gianfelici A, et al. Does early repolarization in the athlete have analogies with the Brugada syndrome? Eur Heart J. 2001;22:504–10.CrossRef Blanco M, Bria S, Gianfelici A, et al. Does early repolarization in the athlete have analogies with the Brugada syndrome? Eur Heart J. 2001;22:504–10.CrossRef
42.
go back to reference Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446–52.CrossRefPubMed Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446–52.CrossRefPubMed
43.
go back to reference Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308–39.CrossRefPubMed Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308–39.CrossRefPubMed
44.
go back to reference Jouven X, Desnos M, Guernot C, et al. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99:1978–83.CrossRefPubMed Jouven X, Desnos M, Guernot C, et al. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99:1978–83.CrossRefPubMed
45.
go back to reference Amitzur G, Schoels W, Visokovsky A, et al. Role of sodium channels in ventricular fibrillation: a study in nonischemic isolated hearts. J Cardiovasc Pharmacol. 2000;36:785–93.CrossRefPubMed Amitzur G, Schoels W, Visokovsky A, et al. Role of sodium channels in ventricular fibrillation: a study in nonischemic isolated hearts. J Cardiovasc Pharmacol. 2000;36:785–93.CrossRefPubMed
46.
go back to reference Burtscher M, Gatterer H, Philippe M, et al. Effects of a single low-dose acetaminophen on body temperature and running performance in the heat: a pilot project. Int J Physiol Pathophysiol Pharmacol. 2013;5:190–3.PubMedPubMedCentral Burtscher M, Gatterer H, Philippe M, et al. Effects of a single low-dose acetaminophen on body temperature and running performance in the heat: a pilot project. Int J Physiol Pathophysiol Pharmacol. 2013;5:190–3.PubMedPubMedCentral
47.
go back to reference Corrado D, Basso C, Pavel A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA. 2006;296:1593–601.CrossRefPubMed Corrado D, Basso C, Pavel A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA. 2006;296:1593–601.CrossRefPubMed
48.
go back to reference Colman N, Bakker A, Linzer M, et al. Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace. 2009;11:937–43.CrossRefPubMed Colman N, Bakker A, Linzer M, et al. Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace. 2009;11:937–43.CrossRefPubMed
49.
go back to reference Nordkamp OLR, Vink AS, Wilde AA, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm. 2015;12:367–75.CrossRef Nordkamp OLR, Vink AS, Wilde AA, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm. 2015;12:367–75.CrossRef
Metadata
Title
Athletes with channelopathy may be eligible to play
Authors
N. M. Panhuyzen-Goedkoop
A. A. M. Wilde
Publication date
01-03-2018
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 3/2018
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-018-1077-5

Other articles of this Issue 3/2018

Netherlands Heart Journal 3/2018 Go to the issue